SVRA
Savara Inc.
Biotechnology · Healthcare · United States
4.82
close · 2026-10-30
value
80
cheaper than peers80
quality
29
stronger fundamentals29
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| earnings yield, 3 years ago | -5.2% | 87 |
| earnings yield, 2 years ago | -6.8% | 80 |
| cash flow yield, 3 years ago | -3.5% | 72 |
| earnings yield, 1 year ago | -10.0% | 71 |
| cash flow yield, 2 years ago | -5.2% | 70 |
| earnings yield, latest year | -11.0% | 69 |
| cash flow yield, latest year | -10.2% | 65 |
| cash flow yield, 1 year ago | -9.0% | 63 |
| price to book | 8.53× | 16 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 0.0% | 50 |
| return on equity | -80.0% | 39 |
| debt to equity | 17.1% | 30 |
3 of 4 measures available
Facts
| market cap | $990M |
| free cash flow | -$57.7M |
| employees | 70 |
| first trade | 2017-04-28 |
| next earnings | not reported |
| fundamentals updated | 2026-08-03 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.53 | -0.48 | -0.33 | -0.25 |
| free cash flow | -$101.1M | -$89.1M | -$51.4M | -$34.6M |
| net income | -$118.8M | -$95.9M | -$54.7M | -$38.1M |
| revenue | $0 | $0 | $0 | $0 |
| unusual items | -$236,000 | $51,000 | $76,000 | -$19,000 |